Total Funding
68
56
Total FundingSeries B raised
Growth Score 68 in past quarter
-9 pts
Heat Score 56 in past quarter
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
31069
Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease.
- Jochen Reiser: Scientific Co-Founder & Scientific Advisory Board Member
Blaine McKee: President & Chief Executive OfficerPast Role: 480 Biomedical, Executive Vice President & Chief Business Officer
About the Company
Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease. Founded by world-renowned experts in renal disease, Walden is applying its unique, systems-based approach to address the intersection between the pathology and biology of kidney disease.